AU2010323101B2 - Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions - Google Patents

Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions Download PDF

Info

Publication number
AU2010323101B2
AU2010323101B2 AU2010323101A AU2010323101A AU2010323101B2 AU 2010323101 B2 AU2010323101 B2 AU 2010323101B2 AU 2010323101 A AU2010323101 A AU 2010323101A AU 2010323101 A AU2010323101 A AU 2010323101A AU 2010323101 B2 AU2010323101 B2 AU 2010323101B2
Authority
AU
Australia
Prior art keywords
crown
formula
group
crown ether
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2010323101A
Other languages
English (en)
Other versions
AU2010323101A1 (en
Inventor
Paolo Botti
Sylvie Tchertchian
Doriane Theurillat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Capsugel Belgium NV
Original Assignee
Capsugel Belgium NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Capsugel Belgium NV filed Critical Capsugel Belgium NV
Publication of AU2010323101A1 publication Critical patent/AU2010323101A1/en
Application granted granted Critical
Publication of AU2010323101B2 publication Critical patent/AU2010323101B2/en
Assigned to CAPSUGEL BELGIUM NV reassignment CAPSUGEL BELGIUM NV Request for Assignment Assignors: ARISGEN SA
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2010323101A 2009-11-25 2010-11-25 Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions Ceased AU2010323101B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09014693.7 2009-11-25
EP09014693A EP2332929A1 (en) 2009-11-25 2009-11-25 Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions
PCT/EP2010/068224 WO2011064300A1 (en) 2009-11-25 2010-11-25 Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions

Publications (2)

Publication Number Publication Date
AU2010323101A1 AU2010323101A1 (en) 2012-06-07
AU2010323101B2 true AU2010323101B2 (en) 2014-10-02

Family

ID=42101959

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010323101A Ceased AU2010323101B2 (en) 2009-11-25 2010-11-25 Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions

Country Status (10)

Country Link
US (1) US8624044B2 (enExample)
EP (2) EP2332929A1 (enExample)
JP (1) JP5848708B2 (enExample)
CN (1) CN102770421B (enExample)
AU (1) AU2010323101B2 (enExample)
BR (1) BR112012012539B8 (enExample)
CA (1) CA2783306C (enExample)
ES (1) ES2557916T3 (enExample)
IL (1) IL219966A (enExample)
WO (1) WO2011064300A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102770152B (zh) 2009-11-25 2016-07-06 阿瑞斯根股份有限公司 肽类的粘膜递送
EP2526971A1 (en) * 2011-05-25 2012-11-28 ArisGen SA Mucosal delivery of drugs
EP3000811B1 (en) 2014-09-24 2017-11-08 Friedrich-Alexander-Universität Erlangen-Nürnberg Crown Ether Complexes and Methods for Poducing the Same
EP3863686A1 (en) * 2018-10-12 2021-08-18 Advanced Accelerator Applications International S.A. Pharmaceutical composition comprising a radiolabeled gprp antagonist and a surfactant

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1905454A1 (en) * 2006-09-27 2008-04-02 Paolo Botti Formulations comprising cyclic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4113739A (en) * 1974-01-28 1978-09-12 The Dow Chemical Company Process for preparation of (poly)cyclic polyethers
US4474963A (en) * 1980-11-03 1984-10-02 W. R. Grace & Co. Crown ether compositions with sidearms affording enhanced cation binding
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
DE851925T1 (de) 1995-09-21 2003-08-14 Genentech Inc., San Francisco Varianten des menschlichen wachstumshormons

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1905454A1 (en) * 2006-09-27 2008-04-02 Paolo Botti Formulations comprising cyclic compounds

Also Published As

Publication number Publication date
WO2011064300A1 (en) 2011-06-03
CN102770421B (zh) 2014-11-26
IL219966A0 (en) 2012-07-31
IL219966A (en) 2014-12-31
CA2783306C (en) 2021-01-19
EP2332929A1 (en) 2011-06-15
ES2557916T3 (es) 2016-01-29
CN102770421A (zh) 2012-11-07
JP5848708B2 (ja) 2016-01-27
BR112012012539B1 (pt) 2021-05-11
US8624044B2 (en) 2014-01-07
EP2504327A1 (en) 2012-10-03
JP2013512221A (ja) 2013-04-11
US20120301401A1 (en) 2012-11-29
CA2783306A1 (en) 2011-06-03
BR112012012539A2 (pt) 2016-05-03
EP2504327B1 (en) 2015-07-29
BR112012012539B8 (pt) 2021-05-25
AU2010323101A1 (en) 2012-06-07

Similar Documents

Publication Publication Date Title
IL220003A (en) A drug release device
AU2007302270B2 (en) Formulations comprising cyclic compounds
AU2010323101B2 (en) Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions
EP4431116A1 (en) Epsilon-poly-l-lysine-based drug conjugate, intermediate thereof, and application thereof
US20220289903A1 (en) Polymer and composition from renewable source
CN112300099A (zh) 药物的缩酮衍生物及其制备方法、药物组合物和用途
Liu et al. Sulfonatoproxylated cucurbit [7] urils as highly water-soluble and biocompatible excipients for solubilizing poorly soluble drugs and improving the bioavailability of indomethacin
AU2014390729B2 (en) Novel polymer-based hydrotropes for hydrophobic drug delivery
WO2019079141A1 (en) MACROMOLECULAR PLATFORM FOR TARGETING THE SCAVENGER A1 RECEIVER
KR20070071027A (ko) 파클리탁셀 또는 이의 유도체를 포함하는 수용성 프로드럭화합물 및 이의 제조방법

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: CAPSUGEL BELGIUM NV

Free format text: FORMER OWNER(S): ARISGEN SA

MK14 Patent ceased section 143(a) (annual fees not paid) or expired